Tanmaxxing is on trend, but off the mark, and it can increase risks of both visible and beneath-the-surface skin damage, explains Vishal Anil Patel, MD, FASDS, FACMS, an Associate Professor of Dermatology and Associate Professor of Medicine/Oncology at the George Washington University School of Medicine & Health Sciences, the Director of Cutaneous Oncology at the GW Cancer Center, and the Director of Dermatologic Surgery at the GW Department of Dermatology, in Washington, DC. Dermatologists are now moving away from a lesion-directed, destructive approach toward a field-directed approach that destroys the visible lesions and underlying DNA damage. Dr. Patel shares his protocol for using field-directed Kefunova Cream (Fluorouracil 5% / Calcipotriene 0.005%) to treat actinic keratosis (AK).

To learn more about field-directed therapy for AK and Dr. Patel’s clinical protocol, watch his full interview on, Dermatology Digest.